The FDA commissioned the report to provide an update on current evidence on research, care, and education in the pain field, and to identify actionable measures for the FDA to more adequately address the ongoing opioid epidemic.
However, the number of opioids prescribed decreased between 2010 and 2015.
Among the nearly 40 million Americans who have a mental health condition, about 19% use prescription opioids.
Researchers found that back pain patients are also more likely to get higher doses of opioids.
Ketamine may alleviate depression, pain, and adverse effects associated with opioid treatment.
Clinicians should consider limiting pre-TKA opioid prescriptions to optimize the benefits of TKA.
Many PA students and practicing PAs did not feel that their PA program adequately trained them to screen for opioid abuse.
Oral corticosteroids could be an alternative symptomatic treatment for acute sore throat, which is a significant burden in primary care and a source of inappropriate antibiotic prescribing.
Mindfulness-based stress reduction was associated with short-term benefits for pain intensity and physical functioning.
Administration of acetaminophen at the recommended dosage yields serum concentrations below 10 µg/mL due to increased elimination.
Researchers found that some surgery patients may face a higher risk of becoming dependent on opioids.
The recently released CDC guidelines on opioid prescribing remain a topic of debate.
Radiofrequency treatment is an effective option for treating refractory chronic knee, hip, and shoulder joint pain.
Patients with chronic pain who are hospitalized have a higher risk of morbidity and mortality, longer lengths of stay, and more frequent readmissions than patients without chronic pain.
At 1 month after the intervention, the percentage of responders was higher in the GC IDI group than the control group.
The drug combination significantly contributes to the overall population risk of opioid overdose.
The Veterans Administration and Department of Defense issue a clinical practice guideline regarding opioid therapy for chronic pain in veterans.
The ACP has released 3 recommendations for the treatment of patients with acute, subacute, and chronic low back pain.
Intravenous lidocaine is safe for reducing pain in patients in the ICU with varying degrees of organ dysfunction.
The toolkit will provide healthcare professionals with adequate tools to manage their patients' pain.
Researchers identify strategies that could ensure access to naloxone.
Recent data suggests that a virtual reality game could reduce pain by as much as one-half.
A program based on cognitive behavioral therapy and physical exercise could improve pain self-management in patients with complex pain.
Intrarosa provides an additional treatment option for women with dyspareunia caused by vulvar and vaginal atrophy.
Lidocaine patches may be effective for patients who are in pain but are looking to avoid drugs that could be addictive.
Researchers conducted an examination in patients over 65 years with moderate-to-severe pain in an academic emergency department.
Conditions such as chronic disease, mental illness, or substance abuse commonly overlap with each other and with poverty, which contributes to poor health.
Patients would like more thorough conversations with their primary care physician over the use of naloxone.
No significant differences were observed among treatments for pediatric migraines.
The average total cost was lower for pregabalin treatment due to lower use of concomitant medications, fewer primary care visits, and fewer sick days.